A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 6, Pages e20669
Publisher
Public Library of Science (PLoS)
Online
2011-06-18
DOI
10.1371/journal.pone.0020669
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis
- (2016) Xinle Wu et al. Aging-US
- High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli
- (2010) Huiyan Wang et al. BMC BIOTECHNOLOGY
- Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system
- (2010) Catherine E. Kang et al. JOURNAL OF CONTROLLED RELEASE
- FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model
- (2010) Taeko Uonaga et al. Islets
- PEG conjugates in clinical development or use as anticancer agents: An overview
- (2009) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects
- (2009) Jing Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Different roles of N- and C- termini in the functional activity of FGF21
- (2009) Radmila Micanovic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Increasing Solubility of Proteins and Peptides by Site-Specific Modification with Betaine
- (2008) Junpeng Xiao et al. BIOCONJUGATE CHEMISTRY
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- FGF21 N- and C-termini play different roles in receptor interaction and activation
- (2008) Junming Yie et al. FEBS LETTERS
- FGF21 is an Akt-regulated myokine
- (2008) Yasuhiro Izumiya et al. FEBS LETTERS
- Physiological Regulation and Disorders of Phosphate Metabolism -Pivotal Role of Fibroblast Growth Factor 23-
- (2008) Seiji Fukumoto INTERNAL MEDICINE
- βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c
- (2008) Masashi Suzuki et al. MOLECULAR ENDOCRINOLOGY
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now